GIALLONGO, CESARINA
 Distribuzione geografica
Continente #
NA - Nord America 2.881
EU - Europa 2.336
AS - Asia 1.080
AF - Africa 271
SA - Sud America 227
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 6.800
Nazione #
US - Stati Uniti d'America 2.815
IT - Italia 1.498
SG - Singapore 532
CN - Cina 341
IE - Irlanda 287
CI - Costa d'Avorio 205
BR - Brasile 202
UA - Ucraina 134
DE - Germania 102
RU - Federazione Russa 59
CA - Canada 55
VN - Vietnam 50
SN - Senegal 49
FI - Finlandia 47
KR - Corea 43
FR - Francia 42
GB - Regno Unito 34
SE - Svezia 32
IN - India 30
CZ - Repubblica Ceca 23
NL - Olanda 19
JP - Giappone 18
BE - Belgio 15
CH - Svizzera 11
EC - Ecuador 11
BD - Bangladesh 10
HK - Hong Kong 9
MX - Messico 9
PL - Polonia 8
AR - Argentina 7
LB - Libano 7
UZ - Uzbekistan 7
NG - Nigeria 6
AE - Emirati Arabi Uniti 5
GR - Grecia 5
MA - Marocco 5
AT - Austria 4
IL - Israele 4
TR - Turchia 4
AU - Australia 3
IQ - Iraq 3
NO - Norvegia 3
PK - Pakistan 3
AL - Albania 2
ES - Italia 2
LT - Lituania 2
PT - Portogallo 2
TN - Tunisia 2
UY - Uruguay 2
VE - Venezuela 2
AM - Armenia 1
AZ - Azerbaigian 1
CL - Cile 1
CO - Colombia 1
DZ - Algeria 1
EG - Egitto 1
EU - Europa 1
GE - Georgia 1
HN - Honduras 1
HR - Croazia 1
IR - Iran 1
JO - Giordania 1
KE - Kenya 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
MK - Macedonia 1
NI - Nicaragua 1
NP - Nepal 1
OM - Oman 1
PH - Filippine 1
PS - Palestinian Territory 1
PY - Paraguay 1
RO - Romania 1
RS - Serbia 1
SI - Slovenia 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZA - Sudafrica 1
Totale 6.800
Città #
Santa Clara 642
Chandler 453
Catania 407
Singapore 377
Chicago 285
Dublin 284
Abidjan 204
Jacksonville 155
Boardman 123
Ashburn 112
Civitanova Marche 91
Florence 83
Houston 74
Cambridge 68
Lawrence 68
Andover 64
Rome 63
Hefei 51
Dakar 49
Dong Ket 44
Milan 43
Munich 43
Seoul 43
Nanjing 42
Toronto 38
Des Moines 36
Beijing 35
Palermo 33
Misterbianco 26
Bremen 25
Bronte 25
Wilmington 24
Messina 23
Los Angeles 21
Bari 20
The Dalles 20
Brno 19
Helsinki 19
Saint Petersburg 19
San Mateo 19
Falls Church 18
Nanchang 18
Shenyang 17
Council Bluffs 16
Turku 16
Washington 16
Dearborn 14
Fukuoka 14
Brussels 13
Paris 13
Turin 13
Hebei 12
Kochi 12
Lappeenranta 12
Augusta 11
Columbus 11
Ottawa 11
Moscow 10
Seattle 10
São Paulo 10
Changsha 9
Guangzhou 9
Hong Kong 9
Jiaxing 9
New York 9
Aci Catena 8
Acireale 8
Tianjin 8
Warsaw 8
Genoa 7
Hanover 7
Ragusa 7
San Giovanni la Punta 7
Abuja 6
Brooklyn 6
Den Haag 6
Hanoi 6
Mascalucia 6
Torino 6
Vicenza 6
Amsterdam 5
Belpasso 5
Boston 5
Floridia 5
Grafing 5
Jinan 5
Naples 5
Padova 5
Pozzallo 5
Aachen 4
Agrate Brianza 4
Belo Horizonte 4
Bernareggio 4
Capri Leone 4
Casablanca 4
Forcoli 4
Gallipoli 4
Giarre 4
Kunming 4
Lentini 4
Totale 4.773
Nome #
Activity-Dependent Neuroprotective Protein (ADNP)-Derived Peptide (NAP) Counteracts UV-B Radiation-Induced ROS Formation in Corneal Epithelium 168
α-Lipoic Acid Reduces Iron-induced Toxicity and Oxidative Stress in a Model of Iron Overload 161
Heme oxygenase-1 nuclear translocation regulates bortezomib-induced cytotoxicity and mediates genomic instability in myeloma cells. 137
Biological properties of Cakile maritima Scop. (Brassicaceae) extracts 133
CXCL12/CXCR4 axis supports mitochondrial trafficking in tumor myeloma microenvironment 125
Heme Oxygenase Inhibition Sensitizes Neuroblastoma Cells to Carfilzomib 115
Inhibition of TLR4 signaling affects mitochondrial fitness and overcomes bortezomib resistance in myeloma plasma cells 111
Antimicrobial and anti-proliferative effects of skin mucus derived from dasyatis pastinaca (Linnaeus, 1758) 109
Biological properties of itraconazole-SLN 105
Clobetasol promotes neuromuscular plasticity in mice after motoneuronal loss via sonic hedgehog signaling, immunomodulation and metabolic rebalancing 105
Focus on Osteosclerotic Progression in Primary Myelofibrosis 100
Ixazomib improves bone remodeling and counteracts sonic hedgehog signaling inhibition mediated by myeloma cells 96
Clobetasol modulates adult neural stem cell growth via canonical hedgehog pathway activation 94
Effect of lipoic acid on the biochemical mechanisms of resistance to bortezomib in SH-SY5Y neuroblastoma cells 92
Monocytic myeloid-derived suppressor cells as prognostic factor in chronic myeloid leukaemia patients treated with dasatinib 90
Mitochondrial Functions, Energy Metabolism and Protein Glycosylation are Interconnected Processes Mediating Resistance to Bortezomib in Multiple Myeloma Cells 90
Bortezomib modulates CHIT1 and YKL40 in monocyte-derived osteoclast and in myeloma cells. 89
Antiproliferative and Antiangiogenic Effects of Punica granatum Juice (PGJ) in Multiple Myeloma (MM) 89
Immune off-target effects of Brentuximab Vedotin in relapsed/refractory Hodgkin Lymphoma 89
Anaplastic thyroid cancer cells reduce CD71 levels to increase iron overload tolerance 88
A cytoprotective role for the heme oxygenase-1/CO pathway during neural differentiation of human mesenchymal stem cells 87
Mesenchymal stromal cells in tumor microenvironment remodeling of BCR-ABL negative myeloproliferative diseases 85
Glioblastoma mesenchymal subtype enhances antioxidant defence to reduce susceptibility to ferroptosis 85
Role of 17β-Estradiol on Cell Proliferation and Mitochondrial Fitness in Glioblastoma Cells 84
TLR4 signaling drives mesenchymal stromal cells commitment to promote tumor microenvironment transformation in multiple myeloma 83
Iron regulates myeloma cell/macrophage interaction and drives resistance to bortezomib 83
In-vitro NET-osis induced by COVID-19 sera is associated to severe clinical course in not vaccinated patients and immune-dysregulation in breakthrough infection 83
Lactate Induces the Expressions of MCT1 and HCAR1 to Promote Tumor Growth and Progression in Glioblastoma 82
ACVR1: A Novel Therapeutic Target to Treat Anemia in Myelofibrosis 81
SPARC expression in CML is associated to imatinib treatment and to inhibition of leukemia cell proliferation 81
Hedgehog signaling pathways in multiple myeloma 80
PMN-MDSC and arginase are increased in myeloma and may contribute to resistance to therapy 80
Biochemical and clinical relevance of alpha lipoic acid: antioxidant and anti-inflammatory activity, molecular pathways and therapeutic potential 79
High-density neutrophils in MGUS and multiple myeloma are dysfunctional and immune-suppressive due to increased STAT3 downstream signaling 78
Bortezomib Inhibits Osteoclastogenesis and Bone Resorption Through Modulation of CHIT1 and YKL40 Expression 77
Effects of second-generation tyrosine kinase inhibitors towards osteogenic differentiation of human mesenchymal cells of healthy donors 76
Correction: TLR4 signaling drives mesenchymal stromal cells commitment to promote tumor microenvironment transformation in multiple myeloma (Cell Death & Disease, (2019), 10, 10, (704), 10.1038/s41419-019-1959-5) 76
Lactate modulates microglia polarization via IGFBP6 expression and remodels tumor microenvironment in glioblastoma 75
Biological properties of itraconazole-SLNs 75
Plasticity of High-Density Neutrophils in Multiple Myeloma is Associated with Increased Autophagy via STAT3 75
Effects of imatinib mesylate in osteoblastogenesis 74
Pericytes in microvessels: From “mural” function to brain and retina regeneration 73
BORTEZOMIB INHIBITS OSTEOCLASTOGENESIS AND MODULATE CHIT1 AND YKL40 EXPRESSION 72
Mesenchymal Stem Cells (MSC) Regulate Activation of Granulocyte-Like Myeloid Derived Suppressor Cells (G-MDSC) in Chronic Myeloid Leukemia Patients 71
Concomitant and feasible treatment with dasatinib and the anti-EGFR antibody cetuximab plus radiotherapy in a CML patient with multiple squamous neoplasias 71
Chitinase domain containing 1 increase is associated with low survival rate and M0 macrophages infiltrates in colorectal cancer patients 70
Electronic nicotine delivery systems exhibit reduced bronchial epithelial cells toxicity compared to cigarette: the Replica Project 70
Targeted Metabolomics Highlights Dramatic Antioxidant Depletion, Increased Oxidative/Nitrosative Stress and Altered Purine and Pyrimidine Concentrations in Serum of Primary Myelofibrosis Patients 69
Lactate Rewrites the Metabolic Reprogramming of Uveal Melanoma Cells and Induces Quiescence Phenotype 68
Clinical outcome of SARS-CoV-2 infections occurring in multiple myeloma patients after vaccination and prophylaxis with tixagevimab/cilgavimab 67
CIRCULATING ARGINASE-1 IN SERUM IS A NOVEL BIO-MARKERIN HODGKIN LYMPHOMA 67
Bortezomib Could Reduce Cell Viability by Activation of Heme Oxygenase 1 in Multiple Myeloma Cells 66
The Role of Epigenetics in Neuroinflammatory-Driven Diseases 64
The Heme Oxygenase System in Hematological Malignancies 63
MONOCYTIC MYELOID DERIVED SUPPRESSOR CELLS (M-MDSC) AS PROGNOSTIC FACTOR IN DASATINIB TREATED PATIENTS WITH CHRONIC MYELOID LEUKEMIA 63
BRIT1/MCPH1 expression in chronic myeloid leukemia and its regulation of the G2/M checkpoint. 62
Clinical impact of the immunome in lymphoid malignancies: the role of Myeloid-Derived Suppressor Cells 62
Neuroprotective Role of α-Lipoic Acid in Iron-Overload-Mediated Toxicity and Inflammation in In Vitro and In Vivo Models 61
Lactate trafficking inhibition restores sensitivity to proteasome inhibitors and orchestrates immuno-microenvironment in multiple myeloma 61
Neuroactive molecules and growth factors modulate cytoskeletal protein expression during astroglial cell proliferation and differentiation in culture 61
Myeloid-derived suppressor cells in Chronic myeloid leukemia 61
Modulation of extracellular signal-related kinase, cyclin D1, glial fibrillary acidic protein, and vimentin expression in estradiol-pretreated astrocyte cultures treated with competence and progression growth factors 61
Proteomic analysis reveals autophagy as pro-survival pathway elicited by long-term exposure with 5-azacitidine in high-risk myelodysplasia 61
Nuclear translocation of Heme oxygenase-1 confers resistance to imatinib in chronic myeloid leukemia cells 59
Ruxolitinib treatment in myelofibrosis and polycythemia vera causes suboptimal humoral immune response following standard and booster vaccination with BNT162b2 mRNA COVID-19 vaccine 58
GRANULOCYTE-LIKE MYELOID DERIVED SUPPRESSOR CELLS ARE INCREASED IN MULTIPLE MYELOMA DUE TO IMMUNOLOGICAL DYSREGULATION OF MESENCHYMAL STEM CELLS 58
BRIT1/MCPH1 expression in chronic myeloid leukemia and its regulation of the G2/M checkpoint 57
Mitochondrial Bioenergetics at the Onset of Drug Resistance in Hematological Malignancies: An Overview 57
MacroH2A1.1 as a crossroad between epigenetics, inflammation and metabolism of mesenchymal stromal cells in myelodysplastic syndromes 56
The prognostic value of the myeloid-mediated immunosuppression marker Arginase-1 in classic Hodgkin lymphoma. 54
OVEREXPRESSION OF ARGINASE AND PROK-2 MAKES NEUTROPHILS OF MULTIPLE MYELOMA DYSFUNCTIONAL AND IMMUNOSUPPRESSIVE 53
Myelofibrosis and Survival Prognostic Models: A Journey between Past and Future 51
Engagement of Mesenchymal Stromal Cells in the Remodeling of the Bone Marrow Microenvironment in Hematological Cancers 51
IMPAIRED NEUTROPHIL FUNCTION IN PATIENTS WITH ACUTE LEUKEMIA 51
Proteasome inhibitors as a possible therapy for SARS-CoV-2 50
TLR4 Signaling and Heme Oxygenase-1/Carbon Monoxide Pathway Crosstalk Induces Resiliency of Myeloma Plasma Cells to Bortezomib Treatment 48
Myeloid derived suppressor cells (MDSCs) are increased and exert immunosuppressive activity together with polymorphonuclear leukocytes (PMNs) in chronic myeloid leukemia patients 48
IGFBP-6/sonic hedgehog/TLR4 signalling axis drives bone marrow fibrotic transformation in primary myelofibrosis 48
Prediction of Survival and Prognosis Migration from Gold-Standard Scores in Myelofibrosis Patients Treated with Ruxolitinib Applying the RR6 Prognostic Model in a Monocentric Real-Life Setting 47
LENALIDOMIDE TREATMENT IS ABLE TO RESTORE REGULATORY T CELLS IN MULTIPLE MYELOMA PATIENTS 47
Immunoproteasome Genes Are Modulated in CD34+ JAK2V617F Mutated Cells from Primary Myelofibrosis Patients 47
The Role of Inflammation and Inflammasome in Myeloproliferative Disease 46
Monocytic myeloid derived suppressor cells in hematological malignancies 45
Pituitary Adenylate Cyclase-Activating Polypeptide Protects Corneal Epithelial Cells against UV-B-Induced Apoptosis via ROS/JNK Pathway Inhibition 45
Imatinib increases cytotoxicity of melphalan and their combination allows an efficient killing of chronic myeloid leukemia cells 44
Correction to: Neuroprotective Role of α-Lipoic Acid in Iron-Overload-Mediated Toxicity and Inflammation in In Vitro and In Vivo Models (Antioxidants, (2022), 11, 8, (1596), 10.3390/antiox11081596) 42
Overexpression of heme oxygenase-1 increases human osteoblast stem cell differentiation. 41
Uveal melanoma cells elicit retinal pericyte phenotypical and biochemical changes in an in vitro model of coculture 40
The pharmacotherapeutic management of patients with myelofibrosis: looking beyond JAK inhibitors 38
Granulocyte-like myeloid derived suppressor cells (G-MDSC) are increased in multiple myeloma and are driven by dysfunctional mesenchymal stem cells (MSC) 38
Deficiency and haploinsufficiency of histone macroH2A1.1 in mice recapitulate hematopoietic defects of human myelodysplastic syndrome 38
Immune Response and Breakthrough Infection Risk After SARS-CoV-2 Vaccines in Patients with Hemoglobinopathy: A Single Center Experience 37
The Pleiotropic Effects of Fumarate: From Mitochondrial Respiration to Epigenetic Rewiring and DNA Repair Mechanisms 37
IGFBP-6: At the Crossroads of Immunity, Tissue Repair and Fibrosis 35
Ixazomib inhibits osteoclastogenesis and promotes osteogenic differentiation in vitro 30
MESENCHYMAL STEM CELLS FROM CML PATIENTS REGULATE MYELOID DERIVED SUPPRESSOR CELLS ACTIVATION 29
Mesenchymal Stem Cells (MSC) from Patients with Multiple Myeloma Promote Myeloid Cells to Become Granulocytic-Myeloid-Derived Suppressor Cells (G-MDSC) with Immunosuppressive, Bone Resorption and Pro-Angiogenic Activity 26
Lactate accumulation promotes immunosuppression and fibrotic transformation of bone marrow microenvironment in myelofibrosis 25
Mesenchymal Stromal Cells (MSC) As Key Players in the Tumor Microenvironment Transformation from MGUS to Myeloma 25
Immune responses to oligomeric α-synuclein in Parkinson’s disease peripheral blood mononuclear cells 23
Totale 6.933
Categoria #
all - tutte 27.198
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.198


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021466 19 19 35 32 111 16 61 11 30 7 49 76
2021/2022653 41 77 10 4 116 26 101 49 51 31 18 129
2022/20231.368 96 112 40 144 111 188 19 237 267 44 71 39
2023/2024928 55 140 39 40 47 203 40 88 4 25 168 79
2024/20252.886 42 456 155 198 522 357 157 136 175 226 242 220
2025/202639 39 0 0 0 0 0 0 0 0 0 0 0
Totale 7.003